The Directorate of Drugs and Biological Products of the
Colombian Ministry of Health (MoH)– now requires the
pharmaceutical drug industry to submit the corresponding Unique
Drug Identifier (IUM, according to its Spanish acronym) for all
pharmaceuticals for human use. The change is a result of Resolution
No. 3166 in force since 2015, which defined and implemented the
data standard for pharmaceuticals for human use in Colombia.
Interested parties should request the IUM for the MoH, as it
will be mandatory for issuing new sanitary registrations and for
the approval of non-available life-saving medications. According to
the provisions of the aforementioned resolution, the IUM shall be
filed as follows:
1) The IUM previously granted shall be presented to the MoH for
each commercial presentation of the dossier requested within.
2) To file the application before the National Food and Drug
Surveillance Institute (INVIMA) under the Colombian MoH, it is
required to submit the IUM in hard copy for the corresponding
3) Once the application is filed, the procedure will continue
according to current practice; and, at the time of the examination,
the correlation between the information provided to obtain the IUM
and the information filed by the interested party before the INVIMA
will be verified.
4) According to MoH's guidelines, lack of conformity will
consequently imply requiring a new IUM filing; this shall resolve
the inconsistency as well as other technical and legal aspects
5) If such sanitary registration is approved, the IUM will be
included in the resolution of this new sanitary registration.
For further information, visit the ministry website at www.minsalud.gov.co and click on the IUM
The Mexican Ministry of Health recently completed a regulatory framework for registering biosimilar drugs and biotechnologies used in treating common chronic conditions like diabetes, arthritis, and hypertension.
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules
for using substances subject to special control in order to provide easier access to drugs
Resolution RDC No. 40/2015 of the Brazilian health surveillance agency (ANVISA), published in the federal gazette (DOU) on August 27, 2015, introduced important changes to the record (cadastro) of health products...
Medical devices are any instrument, apparatus, application, material or article, including software, used by themselves or in tandem, and defined by the manufacturer to be used directly on human beings.
On June 6th, 2015, Law No. 20,850, which creates the Financial Protection System for Diagnostics and Treatment of High Costs, and pays posthumous tribute to Luis Ricarte Soto Gallegos, has been published.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).